All Updates

All Updates

icon
Filter
Product updates
VR surgical guidance platform Augmedics announces launch of new FDA-cleared features
Extended Reality
Mar 8, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Extended Reality

Extended Reality

Mar 8, 2023

VR surgical guidance platform Augmedics announces launch of new FDA-cleared features

Product updates

  • VR surgical guidance platform Augmedics announced the launch of a new set of FDA-cleared features, following its 3,000th patent milestone.

  • The update includes AI image enhancement and customizable views, expanding the capabilities of the company’s xvision, Spine System. The system's clearance has been extended to cover cervical and iliosacral indications, allowing surgeons to benefit from xvision's navigation system in posterior cervical and pelvic approaches, where anatomic visualization challenges exist. The rollout of the solution, which began in January, will be completed by the end of the first quarter and is the company’s largest, since the commercial launch of xvision .

  • Analyst QuickTake: The announcement of additional xvision features follows growth in Augmedics consumer base, with the company having received a federal supply schedule contract in November 2022 , and having completed 2,000 commercial xvision cases in August 2022 .

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.